Sponsored By:
Home
About
Advertising
Promoted Listings
Purchase Data
Weekly Update
Data Licensing
Contact
Sentynl Therapeutics
is defunct.
Fate: Bought by Zydus Cadila, Feb 2017, $171M
------------------
If you believe any of this information is incorrect, please
let us know
.